$-0.28 EPS Expected for IRIDEX (IRIX); Cipher Capital LP Trimmed Its D R Horton (DHI) Holding

October 12, 2017 - By Adrian Erickson

Analysts expect IRIDEX Corporation (NASDAQ:IRIX) to report $-0.28 EPS on November, 2.They anticipate $0.21 EPS change or 300.00% from last quarter’s $-0.07 EPS. After having $-0.24 EPS previously, IRIDEX Corporation’s analysts see 16.67% EPS growth. About 5,027 shares traded. IRIDEX Corporation (NASDAQ:IRIX) has declined 35.41% since October 12, 2016 and is downtrending. It has underperformed by 52.11% the S&P500.

Cipher Capital Lp decreased D R Horton Inc (DHI) stake by 50.51% reported in 2017Q2 SEC filing. Cipher Capital Lp sold 58,288 shares as D R Horton Inc (DHI)’s stock rose 10.82%. The Cipher Capital Lp holds 57,100 shares with $1.97 million value, down from 115,388 last quarter. D R Horton Inc now has $15.60 billion valuation. The stock declined 0.22% or $0.09 reaching $41.39 per share. About 1.97 million shares traded. D. R. Horton Inc (NYSE:DHI) has risen 15.56% since October 12, 2016 and is uptrending. It has underperformed by 1.14% the S&P500.

Among 22 analysts covering DR Horton Inc (NYSE:DHI), 14 have Buy rating, 0 Sell and 8 Hold. Therefore 64% are positive. DR Horton Inc had 45 analyst reports since July 30, 2015 according to SRatingsIntel. KeyBanc Capital Markets maintained the shares of DHI in report on Tuesday, September 26 with “Buy” rating. UBS upgraded the shares of DHI in report on Wednesday, August 12 to “Neutral” rating. The stock of D. R. Horton Inc (NYSE:DHI) has “Outperform” rating given on Tuesday, December 13 by Keefe Bruyette & Woods. Keefe Bruyette & Woods maintained the stock with “Buy” rating in Monday, June 5 report. KeyBanc Capital Markets maintained D. R. Horton Inc (NYSE:DHI) on Tuesday, August 22 with “Buy” rating. RBC Capital Markets maintained D. R. Horton Inc (NYSE:DHI) on Wednesday, January 25 with “Outperform” rating. The rating was maintained by Compass Point on Tuesday, November 10 with “Buy”. The rating was downgraded by UBS to “Neutral” on Friday, January 15. On Sunday, August 20 the stock rating was maintained by RBC Capital Markets with “Buy”. Argus Research initiated the shares of DHI in report on Friday, June 17 with “Buy” rating.

Investors sentiment decreased to 1.04 in Q2 2017. Its down 0.08, from 1.12 in 2017Q1. It worsened, as 45 investors sold DHI shares while 183 reduced holdings. 68 funds opened positions while 168 raised stakes. 300.92 million shares or 0.71% less from 303.08 million shares in 2017Q1 were reported. Thomas White International invested 0.15% of its portfolio in D. R. Horton Inc (NYSE:DHI). Commerzbank Aktiengesellschaft Fi has invested 0.01% in D. R. Horton Inc (NYSE:DHI). Bokf Na invested 0.01% in D. R. Horton Inc (NYSE:DHI). Quantitative Mgmt Ltd Liability Corporation accumulated 280,900 shares or 0.15% of the stock. 455,000 are owned by Ruane Cunniff And Goldfarb Incorporated. Koshinski Asset Mngmt Incorporated accumulated 15,363 shares. Clearbridge Lc reported 28,811 shares or 0% of all its holdings. First State Bank reported 59,628 shares. 96,029 are owned by Texas Permanent School Fund. Federated Investors Pa reported 0.05% in D. R. Horton Inc (NYSE:DHI). Marco Mngmt Limited Liability Company has invested 0.17% of its portfolio in D. R. Horton Inc (NYSE:DHI). Bnp Paribas Arbitrage Sa owns 283,652 shares or 0.03% of their US portfolio. Shufro Rose Ltd holds 0.04% of its portfolio in D. R. Horton Inc (NYSE:DHI) for 11,450 shares. 1.49M were reported by Royal Savings Bank Of Canada. Connecticut-based Tudor Investment Et Al has invested 0.02% in D. R. Horton Inc (NYSE:DHI).

Analysts await D. R. Horton Inc (NYSE:DHI) to report earnings on November, 14. They expect $0.86 earnings per share, up 14.67% or $0.11 from last year’s $0.75 per share. DHI’s profit will be $324.14M for 12.03 P/E if the $0.86 EPS becomes a reality. After $0.76 actual earnings per share reported by D. R. Horton Inc for the previous quarter, Wall Street now forecasts 13.16% EPS growth.

Cipher Capital Lp increased Toro Co (NYSE:TTC) stake by 19,404 shares to 30,459 valued at $2.11 million in 2017Q2. It also upped Corelogic Inc (NYSE:CLGX) stake by 24,051 shares and now owns 108,118 shares. Hologic Inc (NASDAQ:HOLX) was raised too.

IRIDEX Corporation is a provider of therapeutic based laser consoles, delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. The company has market cap of $111.74 million. The Firm operates through ophthalmology segment. It currently has negative earnings. The Company’s ophthalmology products consist of laser consoles, delivery devices and consumable instrumentation, including laser probes, and are used in the treatment of serious eye diseases, including the over three causes of irreversible blindness, such as diabetic retinopathy, glaucoma and age-related macular degeneration .

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.